Sulfur, Salicylic Acid, Hydrocortisone
Generic Name: sulfur, salicylic acid, hydrocortisone
Brand Names:
Dermoscribe Seborrheic Dermatitis
PURPOSE SEBORRHEIC DERMATITIS CREAM
Overview
PURPOSE SEBORRHEIC DERMATITIS CREAM
Uses
USE For relief of itching, scaling, redness, flaking and irritation associated with seborrheic dermatitis
Dosage
DIRECTIONS Apply to affected area once or twice daily
Warnings
WARNINGS FOR EXTERNAL USE ONLY. Ask a doctor before use if condition covers a large area of the body When using this product avoid contact with eyes. If contact occurs, rinse eye thoroughly with water Stop use and consult a doctor if condition worsens or does not improve after regular use as directed
Frequently Asked Questions
What is Sulfur, Salicylic Acid, Hydrocortisone used for?▼
USE For relief of itching, scaling, redness, flaking and irritation associated with seborrheic dermatitis
What are the important warnings for Sulfur, Salicylic Acid, Hydrocortisone?▼
WARNINGS FOR EXTERNAL USE ONLY. Ask a doctor before use if condition covers a large area of the body When using this product avoid contact with eyes. If contact occurs, rinse eye thoroughly with water Stop use and consult a doctor if condition worsens or does not improve after regular use as directed
Related Medications
Octinoxate, Octisalate, Homosalate, Oxybenzone, Zinc Oxide
octinoxate, octisalate, homosalate, oxybenzone, zinc oxide
Active ingredients Octinoxate 7.5% Sunscreen Octisalate 5.0% Sunscreen Homosalate 7.0% Sunscreen Oxybenzone 5.0% Sunscreen Zinc Oxide 6.0% Sunscreen
Azithromycine Dihydrate
azithromycine dihydrate
Dosage form: POWDER. Active ingredients: AZITHROMYCIN DIHYDRATE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Onasemnogene Abeparvovec-brve
onasemnogene abeparvovec-brve
11 DESCRIPTION ITVISMA (onasemnogene abeparvovec-brve) is a suspension of an adeno-associated viral vector-based gene therapy for intrathecal injection. It is a recombinant self-complementary AAV9 containing a transgene encoding the human survival motor neuron (SMN) protein, under the control of a cytomegalovirus enhancer/chickenβactin hybrid promoter. ITVISMA has a nominal concentration of 4 × 10 13 vg/mL.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.